The pharmaceutical industry was put on notice Tuesday when two powerful congressional committees placed high drug prices firmly at the top of their agendas. “Drug companies make money hand over fist by raising the prices of their drugs — often without justification and sometimes overnight — while patients are left holding the bill," said House Oversight and Reform Chairman Elijah Cummings (D-Md.) at the House hearing. Over in the Senate, Sen. Chuck Grassley (R-Iowa) was adamant about bringing drug company executives in front of lawmakers to answer questions on high costs.
from Kaiser Health News http://bit.ly/2sVznkT
January 30, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: June 4, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2HgPEph … Read More
Bubble Pop? Brownie Batter? Vapes’ Added Flavors Fuel E-Cig Debate… Read More
Medicaid Advocates See Virginia’s Expansion Decision As Broader Political ShiftVirginia's decision to expand Medicaid after years of resistance is giving some hope that opposition against the issue has lessened in recent years. Meanwhile, in Texas, poor state oversight has led to companies skimping on e… Read More
‘We Weren’t Arresting Our Way Out Of Anything’: How Tiny Police Stations Are Revolutionizing Fight Against Opioid CrisisPolice officers are often the ones on the front lines of the drug epidemic. Fed up with seeing members of their community dying in droves, they've taken matters into their own hands with new tools and initiatives. Meanwhile, … Read More
Outsiders Swoop In Vowing To Rescue Rural Hospitals Short On Hope — And Money… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment